Moreover, some of the prepared analogs exhibited substantial cancer cell specific antiproliferative action and proapoptotic features on androgen therapy refractive p53-deficient PC-3 cells initiated by intrinsic pathways of apoptosis. This evidence concerns the gene TP53 and cancer.